Medical Cannabis: Legal If You’re Lucky Enough to Afford It
In 2018, the UK government quietly admitted something campaigners had been saying for years.
Cannabis has medical value.
For families of children with severe epilepsy, patients suffering chronic pain and people living with conditions such as multiple sclerosis, it was a moment of hope. Cannabis-based medicines became legal to prescribe by specialist doctors.
The headlines suggested Britain had entered a new era.
The reality has been very different.
Today, medical cannabis is legal in Britain—but for most people, it remains practically out of reach.
Legal on paper, inaccessible in practice
When politicians announced medical cannabis would be legal, many assumed patients would soon receive it through the NHS like any other medicine.
Instead, NHS prescriptions remain extremely rare.
Many patients who believe cannabis genuinely improves their quality of life find themselves facing only two realistic options:
- Pay hundreds of pounds through private clinics.
- Continue buying cannabis illegally.
That isn’t a healthcare system based purely on medical need.
It becomes a system influenced by financial means.
The two patients
Imagine two people with chronic pain.
Both have tried conventional medication.
Both struggle to sleep.
Both find cannabis provides relief.
The first can afford private consultations, prescription fees and regular medication costs. They receive pharmaceutical-grade cannabis, labelled, tested and completely legal.
The second cannot.
They buy cannabis from the illegal market because it’s the only option they can realistically afford.
One is considered a patient.
The other risks being treated as a criminal.
Their condition hasn’t changed.
The plant hasn’t changed.
Only their financial circumstances have.
A question of fairness
Supporters of the current system often argue that cannabis should only be available after careful medical assessment.
That is a reasonable principle.
Doctors should oversee treatment.
Patients deserve quality-controlled products.
Medicines should meet proper standards.
The problem isn’t regulation.
The problem is accessibility.
If legal access is so restricted that ordinary people cannot realistically obtain treatment, then prohibition simply continues under a different name.
Britain hasn’t fully solved the issue.
It has created two separate systems:
One for those who can access legal medicine.
Another for everyone else.
The illegal market benefits
Every patient unable to obtain legal treatment represents another customer for the illegal market.
Ironically, prohibition strengthens the very criminal networks politicians claim they want to weaken.
Illegal dealers don’t ask for medical records.
They don’t verify age.
They don’t test potency.
They don’t provide dosage guidance.
And they certainly don’t pay tax.
A functioning legal medical system would reduce demand for illicit suppliers.
Instead, barriers to access often push patients straight back towards them.
Trust is disappearing
This contradiction creates another problem.
Public trust.
When governments acknowledge cannabis has legitimate medical uses while simultaneously treating many users as criminals, people begin questioning whether policy is driven by science or politics.
Trust is difficult to rebuild once people believe laws are inconsistent.
That doesn’t mean every recreational user should suddenly become a medical patient.
Nor does it mean doctors should prescribe cannabis without evidence.
It means the law should make sense.
The uncomfortable reality
Nobody should be forced into the illegal market simply because they cannot afford legal healthcare.
If cannabis genuinely has recognised medical value—and Britain has already accepted that it does—then policymakers need to ask an uncomfortable question.
Is the current system protecting patients?
Or is it protecting the appearance of prohibition?
Looking forward
The debate about cannabis is slowly changing.
It is no longer simply about whether cannabis should be legal.
Increasingly, it is about who benefits from the laws that already exist.
As more countries expand access to medical cannabis, Britain will eventually have to confront a difficult truth:
A medicine available only to those with the money to access it is not equally available at all.
Perhaps the next stage of reform isn’t deciding whether cannabis works.
It’s deciding whether healthcare should depend on your bank balance.